The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anxiety and Panic Disorders Drugs Market Research Report 2024
Synopsis
Anxiety and Panic Disorders Drugs are two kinds of drugs which are usually used in respiratory, inflammation and autoimmunity, cardiovascular and metabolic diseases, oncology, infection, neuroscience, and gastrointestinal.
The global Anxiety and Panic Disorders Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
During 2017, the anxiety and panic disorders antidepressant drugs segment contributed to the majority of the revenue to the overall market and will continue to be the major revenue contributor to the market during the next four years as well. The introduction of newer selective serotonin reuptake inhibitor (SSRIs) with more safer side effects is driving the market segment’s growth in the coming years. Brintellix was approved by the US FDA in September 2013 for the treatment of depression.
This report aims to provide a comprehensive presentation of the global market for Anxiety and Panic Disorders Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anxiety and Panic Disorders Drugs.
Report Scope
The Anxiety and Panic Disorders Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anxiety and Panic Disorders Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anxiety and Panic Disorders Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
AstraZeneca
Eli Lilly
GlaxoSmithKline
Pfizer
Azevan Pharmaceuticals
Baxter
Bristol-Myers Squibb
Segment by Type
Antidepressant Drugs
Anxiolytic Drugs
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anxiety and Panic Disorders Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anxiety and Panic Disorders Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Anxiety and Panic Disorders Drugs are two kinds of drugs which are usually used in respiratory, inflammation and autoimmunity, cardiovascular and metabolic diseases, oncology, infection, neuroscience, and gastrointestinal.
The global Anxiety and Panic Disorders Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
During 2017, the anxiety and panic disorders antidepressant drugs segment contributed to the majority of the revenue to the overall market and will continue to be the major revenue contributor to the market during the next four years as well. The introduction of newer selective serotonin reuptake inhibitor (SSRIs) with more safer side effects is driving the market segment’s growth in the coming years. Brintellix was approved by the US FDA in September 2013 for the treatment of depression.
This report aims to provide a comprehensive presentation of the global market for Anxiety and Panic Disorders Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anxiety and Panic Disorders Drugs.
Report Scope
The Anxiety and Panic Disorders Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anxiety and Panic Disorders Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anxiety and Panic Disorders Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
AstraZeneca
Eli Lilly
GlaxoSmithKline
Pfizer
Azevan Pharmaceuticals
Baxter
Bristol-Myers Squibb
Segment by Type
Antidepressant Drugs
Anxiolytic Drugs
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anxiety and Panic Disorders Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anxiety and Panic Disorders Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Anxiety and Panic Disorders Drugs Market Overview
1.1 Product Overview and Scope of Anxiety and Panic Disorders Drugs
1.2 Anxiety and Panic Disorders Drugs Segment by Type
1.2.1 Global Anxiety and Panic Disorders Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Antidepressant Drugs
1.2.3 Anxiolytic Drugs
1.3 Anxiety and Panic Disorders Drugs Segment by Application
1.3.1 Global Anxiety and Panic Disorders Drugs Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Anxiety and Panic Disorders Drugs Market Size Estimates and Forecasts
1.4.1 Global Anxiety and Panic Disorders Drugs Revenue 2019-2030
1.4.2 Global Anxiety and Panic Disorders Drugs Sales 2019-2030
1.4.3 Global Anxiety and Panic Disorders Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anxiety and Panic Disorders Drugs Market Competition by Manufacturers
2.1 Global Anxiety and Panic Disorders Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anxiety and Panic Disorders Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anxiety and Panic Disorders Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Anxiety and Panic Disorders Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anxiety and Panic Disorders Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anxiety and Panic Disorders Drugs, Product Type & Application
2.7 Anxiety and Panic Disorders Drugs Market Competitive Situation and Trends
2.7.1 Anxiety and Panic Disorders Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anxiety and Panic Disorders Drugs Players Market Share by Revenue
2.7.3 Global Anxiety and Panic Disorders Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anxiety and Panic Disorders Drugs Retrospective Market Scenario by Region
3.1 Global Anxiety and Panic Disorders Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anxiety and Panic Disorders Drugs Global Anxiety and Panic Disorders Drugs Sales by Region: 2019-2030
3.2.1 Global Anxiety and Panic Disorders Drugs Sales by Region: 2019-2024
3.2.2 Global Anxiety and Panic Disorders Drugs Sales by Region: 2025-2030
3.3 Global Anxiety and Panic Disorders Drugs Global Anxiety and Panic Disorders Drugs Revenue by Region: 2019-2030
3.3.1 Global Anxiety and Panic Disorders Drugs Revenue by Region: 2019-2024
3.3.2 Global Anxiety and Panic Disorders Drugs Revenue by Region: 2025-2030
3.4 North America Anxiety and Panic Disorders Drugs Market Facts & Figures by Country
3.4.1 North America Anxiety and Panic Disorders Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anxiety and Panic Disorders Drugs Sales by Country (2019-2030)
3.4.3 North America Anxiety and Panic Disorders Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anxiety and Panic Disorders Drugs Market Facts & Figures by Country
3.5.1 Europe Anxiety and Panic Disorders Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anxiety and Panic Disorders Drugs Sales by Country (2019-2030)
3.5.3 Europe Anxiety and Panic Disorders Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anxiety and Panic Disorders Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Anxiety and Panic Disorders Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anxiety and Panic Disorders Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Anxiety and Panic Disorders Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anxiety and Panic Disorders Drugs Market Facts & Figures by Country
3.7.1 Latin America Anxiety and Panic Disorders Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anxiety and Panic Disorders Drugs Sales by Country (2019-2030)
3.7.3 Latin America Anxiety and Panic Disorders Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anxiety and Panic Disorders Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anxiety and Panic Disorders Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anxiety and Panic Disorders Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anxiety and Panic Disorders Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anxiety and Panic Disorders Drugs Sales by Type (2019-2030)
4.1.1 Global Anxiety and Panic Disorders Drugs Sales by Type (2019-2024)
4.1.2 Global Anxiety and Panic Disorders Drugs Sales by Type (2025-2030)
4.1.3 Global Anxiety and Panic Disorders Drugs Sales Market Share by Type (2019-2030)
4.2 Global Anxiety and Panic Disorders Drugs Revenue by Type (2019-2030)
4.2.1 Global Anxiety and Panic Disorders Drugs Revenue by Type (2019-2024)
4.2.2 Global Anxiety and Panic Disorders Drugs Revenue by Type (2025-2030)
4.2.3 Global Anxiety and Panic Disorders Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Anxiety and Panic Disorders Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anxiety and Panic Disorders Drugs Sales by Application (2019-2030)
5.1.1 Global Anxiety and Panic Disorders Drugs Sales by Application (2019-2024)
5.1.2 Global Anxiety and Panic Disorders Drugs Sales by Application (2025-2030)
5.1.3 Global Anxiety and Panic Disorders Drugs Sales Market Share by Application (2019-2030)
5.2 Global Anxiety and Panic Disorders Drugs Revenue by Application (2019-2030)
5.2.1 Global Anxiety and Panic Disorders Drugs Revenue by Application (2019-2024)
5.2.2 Global Anxiety and Panic Disorders Drugs Revenue by Application (2025-2030)
5.2.3 Global Anxiety and Panic Disorders Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Anxiety and Panic Disorders Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Anxiety and Panic Disorders Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Anxiety and Panic Disorders Drugs Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eli Lilly Anxiety and Panic Disorders Drugs Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GlaxoSmithKline Anxiety and Panic Disorders Drugs Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Anxiety and Panic Disorders Drugs Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Azevan Pharmaceuticals
6.6.1 Azevan Pharmaceuticals Corporation Information
6.6.2 Azevan Pharmaceuticals Description and Business Overview
6.6.3 Azevan Pharmaceuticals Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Azevan Pharmaceuticals Anxiety and Panic Disorders Drugs Product Portfolio
6.6.5 Azevan Pharmaceuticals Recent Developments/Updates
6.7 Baxter
6.6.1 Baxter Corporation Information
6.6.2 Baxter Description and Business Overview
6.6.3 Baxter Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Baxter Anxiety and Panic Disorders Drugs Product Portfolio
6.7.5 Baxter Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Corporation Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb Anxiety and Panic Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bristol-Myers Squibb Anxiety and Panic Disorders Drugs Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anxiety and Panic Disorders Drugs Industry Chain Analysis
7.2 Anxiety and Panic Disorders Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anxiety and Panic Disorders Drugs Production Mode & Process
7.4 Anxiety and Panic Disorders Drugs Sales and Marketing
7.4.1 Anxiety and Panic Disorders Drugs Sales Channels
7.4.2 Anxiety and Panic Disorders Drugs Distributors
7.5 Anxiety and Panic Disorders Drugs Customers
8 Anxiety and Panic Disorders Drugs Market Dynamics
8.1 Anxiety and Panic Disorders Drugs Industry Trends
8.2 Anxiety and Panic Disorders Drugs Market Drivers
8.3 Anxiety and Panic Disorders Drugs Market Challenges
8.4 Anxiety and Panic Disorders Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
